We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
WHX Labs Dubai 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Inhibiting Glycolytic Respiration Stops Tumor Growth

By Biotechdaily staff writers
Posted on 20 Jul 2006
Cancer researchers have described a mechanism that explains how cells buried in the center of tumors and virtually cut off from sources of oxygen manage to survive and replicate.

Investigators at Harvard Medical School (Boston, MA, USA) capitalized on the latest genetic engineering techniques to study the anaerobic glycolytic pathway in tumor cells. They used short hairpin RNAs to knock down the level of lactate dehydrogenase A (LDH-A) in a line of fast-growing breast cancer cells, which effectively prevented the cells from metabolizing pyruvate to lactate. The modified tumor cells were implanted into a group of mice while a control group received untreated cells.

Results published in the June 2006 issue of Cancer Cell revealed that while all the mice in the control group died from cancer within 10 weeks, more than 80% of the animals in the test group survived to the end of the four-month experiment.

Reduction in LDH-A activity forced the cells to rely on oxidative phosphorylation, which was characterized by stimulation of mitochondrial respiration and decrease of mitochondrial membrane potential. When the tumors became too large, the cells at the center were unable to breathe and died off.

"The findings provide us with an insight into a mechanism that had been suspected in the last six or seven decades,” said senior author Dr. Philip Leder, professor of genetics at Harvard Medical School.

The investigators suggested that coupling treatment to prevent glycolysis with drugs to inhibit synthesis of new blood vessels might prove to be an effective anti-cancer regime.



Related Links:
Harvard Medical School

Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Human Estradiol Assay
Human Estradiol CLIA Kit

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
20 Jul 2006  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
20 Jul 2006  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
20 Jul 2006  |   BioResearch